We respect your privacy and use tracking simply to improve your experience - Read more Got it! Search Business overview About us HOME ABOUT US BUSINESS OVERVIEW TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing sterile bone allografts. We are currently helping to transform the treatment of patients in key surgical applications: BioSurgery, Orthopaedics (sports medicine/spine), Dental, General, Plastic Surgery, Urology/Gynaecology, Ophthalmology, and Cardiac. OUR VISION To establish TRG as a leader in the science and innovation of regenerative medicine. Transforming patient care and delivering favourable health economic outcomes. Group snapshot: progress in 2020 £12.8m revenue FY2020 £9.6m cash at 31 December 2020 £13.8m (net) equity fundraise, June 2020 Capacity expansion programme commenced in San Antonio Distribution via strategic partners, direct specialist sales and distribution partners Two new product launches undertaken during 2020 77 Employees 4 Product Line Extensions in Pipeline 3 Global Manufacturing Facilities 7 Countries Supplied to Product portfolio High growth product lines focused on bone, skin (dermis) and birth tissue: Bone BioRinse® Flagship Products ConCelltrate® Applications Spine Foot/ankle Dental Orthopaedics Differentiators Induces new bone growth Faster healing Superior handling Reduced flush out Soft Tissue dCELL® Flagship Products DermaPure® Applications Urogynaecology Sports medicine Open wound Plastics Differentiators Clinical outcomes No second graft site required Stored at room temperature Superior handling Birth Tissue Proprietary Flagship Products AmnioWorks™ Applications Ophthalmology Wound covering Differentiators Clinical outcomes Barrier can provide faster healing Stored at room temperature GLOBAL OPERATIONS INFRASTRUCTURE Platform for international expansion CURRENT LOCATIONS Tissue Regenix, Leeds, UK Cellright Technologies, San Antonio, Texas GBM-V, Rostock, Germany Our values Dedication to patients Passion for innovation Drive for excellence Uncompromising integrity You may also be interested in Our story Business model Our technology © 2021 Tissue Regenix PRODUCTS BioSurgery Orthopaedics Dental Cardiac USEFUL LINKS About us Accreditations and licenses Careers Contact us Investors FOLLOW US ON Twitter LinkedIn YouTube OUR SITES UK Visit https://www.tissueregenixus.com/about-us/business-overview USA Accessibility Cookies Privacy policy Sitemap Terms of Use Designed and developed by Jones and Palmer